RxDoctor Payments Data

Aarron Flowers

Podiatrist · Santa Cruz, CANPI 1144607466

Payments from drug & device makers

What this record shows

The money is spread across several categories — education (46.8%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. 9 manufacturers reported payments, led by Evolution Surgical, Inc at 33.5% of the total. Reporting peaked in 2019 at $8,233 and has fallen 90.5% since, to $785 in 2025. Among podiatrist clinicians in CA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$12,173in general payments, 2019–2025

Across 89 payments — averaging $136.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Evolution Surgical, Inc$4K
  • Arthrex$3K
  • Stryker$2K
  • Paragon 28, Inc.$1K
  • Orthofix Medical, Inc.$1K
  • Zimmer Biomet$273
  • plus $476 from 3 others

What the payments were for

  • Travel & lodging$4,02933%
  • Food & beverage$2,44420%
  • Education$5,70147%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$12,173 in reported general payments places this provider in the 90th percentile of 721 podiatrist providers in California.

See all podiatrist providers in California

Medicare billing

Part B allowed, 2024
$194,091
Medicare patients
578
Services billed
1,886

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gabapentin37$432
Ciclopirox11$355
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav14$120

Paid to pharmacies, not to this prescriber.

Other podiatrist in Santa Cruz

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →